Skip to main content
. 2020 Nov 16;12(11):3393. doi: 10.3390/cancers12113393

Figure 4.

Figure 4

Immunohistochemical FAP and plasma sFAP levels according to CCRCC patients’ cancer-specific survival (CSS). Kaplan–Meier curves and univariate log-rank test showed that FAP expression at tumour centre (A) and border (B) is associated to worse CSS. CCRCC patients with lower sFAP levels than 61.03 ng/mL had worse CSS (C). Simultaneous expression of FAP at tumour centre (D) or border (E) and lower plasma FAP levels than 61.03 ng/mL are associated to worse CSS.